MA (EU) number 
(Invented) name Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate Packaging 
Pack size 
EU/1/17/1222/001  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/002  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/003  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/004  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/005  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/006  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
EU/1/17/1222/007  Efavirenz/Emtricita
bine/Tenofovir 
disoproxil Mylan   
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
600 mg / 
200 mg / 
245 mg 
Film-coated tablet  Oral use 
bottle (HDPE) 
30 tablets 
Film-coated tablet  Oral use 
bottle (HDPE) 
90 (3 x 30) tablets 
(multipack) 
Film-coated tablet  Oral use 
bottle (HDPE) 
90 tablets 
Film-coated tablet  Oral use 
blister (OPA/alu/PE/HDPE/alu) 
30 tablets 
Film-coated tablet  Oral use 
blister (OPA/alu/PE/HDPE/alu) 
90 tablets 
Film-coated tablet  Oral use 
blister (OPA/alu/PE/HDPE/alu) 
Film-coated tablet  Oral use 
blister (OPA/alu/PE/HDPE/alu) 
30 x 1 tablets (unit 
dose) 
90 x 1 tablets (unit 
dose) 
Â 
 
 
 
